Sertranat 50 mg Film-Coated Tablets
Prescription-only oral medicine containing the active substance sertranat
Sertranat is a prescription-only film-coated tablet containing 50 milligrams of the active substance sertranat. As with all prescription medicines, Sertranat is intended to be used under the supervision of a qualified healthcare professional who has evaluated your medical history, current medications, and the condition being treated. This evidence-based guide explains what you should know before taking Sertranat, how oral film-coated tablets are generally used, which interactions and side effects to watch for, and how to store the medicine safely. For indication-specific details such as the exact reason your tablet has been prescribed, always refer to the package leaflet supplied with the medicine and the instructions given by your prescriber.
Quick Facts
Key Takeaways
- Sertranat is a prescription-only film-coated tablet supplied at a strength of 50 milligrams per tablet.
- It is designed to be swallowed whole with water — film-coated tablets should not normally be crushed, chewed, or split unless your prescriber specifically tells you it is safe to do so.
- Always follow the dosing schedule written on your prescription label and in the package leaflet. Do not change the dose or stop treatment on your own.
- Tell your prescriber about every other medicine, supplement, and herbal product you use, including those bought without a prescription, to reduce the risk of drug interactions.
- Seek urgent medical advice if you experience symptoms of a severe allergic reaction, a sudden worsening of your condition, or any side effect that is severe, persistent, or unexpected.
What Is Sertranat and What Is It Used For?
Sertranat is classified as an oral, film-coated tablet for systemic use. The film coating around the tablet core serves several important purposes: it can mask an unpleasant taste, protect the active substance from moisture and light, and help ensure a consistent release of the medicine as the tablet passes through the gastrointestinal tract. Film-coated tablets are one of the most common pharmaceutical dosage forms worldwide because they offer convenient, standardised dosing, long shelf-life, and reliable bioavailability in most patients. Sertranat is designed to be swallowed whole with a glass of water so that the coating remains intact until the tablet reaches the stomach.
As a prescription medicine, Sertranat can only be supplied by a pharmacist against a valid prescription issued by an authorised healthcare professional — typically a physician, or in some jurisdictions a specialist nurse or pharmacist prescriber. The prescription model exists for good reason: a prescriber assesses whether a medicine is clinically appropriate for you, reviews your other medications for possible interactions, checks for contraindications, and arranges follow-up to monitor both the benefits of treatment and any side effects. Self-medication with a prescription product is potentially hazardous because the factors that determine whether a medicine is appropriate — and at what dose — require professional judgement.
The active substance in Sertranat, also called sertranat, is the pharmacologically active ingredient responsible for the medicine’s therapeutic effect. Each 50 milligram tablet delivers a consistent amount of this active substance. In addition to the active ingredient, film-coated tablets contain excipients (inactive ingredients) such as binders, disintegrants, fillers, and colouring agents. The complete list of excipients for Sertranat is provided in the package leaflet and is important for patients with known allergies or intolerances. Details of the specific indication, mechanism of action, and approved clinical uses for Sertranat are provided in the Summary of Product Characteristics (SmPC) and your prescribing information; your doctor or pharmacist can explain these in the context of your personal situation.
Like other prescription oral medicines, Sertranat is intended to be used as part of a structured treatment plan that may include lifestyle changes, monitoring tests, and review appointments. Even small changes to how, when, or whether you take your tablets can significantly affect the outcome of treatment — either by reducing effectiveness or by raising the risk of adverse effects. That is why international regulators, professional bodies, and patient safety organisations all emphasise the importance of strict adherence to the prescribed regimen and open communication with your healthcare team.
Patients in many countries also have the right to ask for the official package leaflet in their own language. This leaflet is the single most authoritative source of product-specific information and is updated when new safety data or indications are approved. If anything in this educational article appears to conflict with the leaflet for your specific pack of Sertranat, you should follow the leaflet and contact your pharmacist or prescriber for clarification.
Never take Sertranat (or any other prescription medicine) that was not prescribed for you personally. Medicines that are safe for one patient may be unsafe for another because of allergies, underlying health conditions, pregnancy, or interactions with other drugs. If you find medicines at home that were previously prescribed but are no longer needed, return them to your pharmacist for safe disposal rather than sharing them with family members or keeping them for possible future use.
What Should You Know Before Taking Sertranat?
Contraindications
Sertranat must not be used by anyone with a known hypersensitivity (allergy) to the active substance sertranat or to any of the excipients listed in the package leaflet. Allergic reactions to oral medicines can vary widely: some people develop a rash, hives, or itching, while others may experience swelling of the face, lips, tongue, or throat, difficulty breathing, or a sudden drop in blood pressure (anaphylaxis). If you have previously reacted to sertranat or to a chemically related substance, tell your prescriber before starting treatment so that an alternative can be considered.
Your doctor may also consider Sertranat contraindicated or unsuitable in specific clinical situations that are fully listed in the Summary of Product Characteristics (SmPC) for the product. Contraindications are not just technicalities — they represent situations in which the risks of treatment clearly outweigh the benefits. If you have been diagnosed with a serious liver or kidney condition, a rare metabolic disorder, or a medical condition that is explicitly mentioned in the leaflet, your prescriber will assess whether Sertranat is safe for you and whether any alternative therapy is appropriate.
Warnings and Precautions
Before starting Sertranat, make sure your doctor knows about your complete medical history. Certain conditions may not strictly contraindicate treatment but can require careful dose adjustment, additional monitoring, or more frequent follow-up. In particular, tell your prescriber if you have any of the following:
- Liver or kidney disease — many medicines are metabolised or excreted through the liver or kidneys, and impaired organ function can affect drug levels and safety.
- Cardiovascular disease — including heart failure, ischaemic heart disease, significant arrhythmias, or uncontrolled high blood pressure.
- Diabetes mellitus — because some medicines can influence blood glucose control or interact with oral antidiabetic drugs and insulin.
- Mental health conditions — such as depression, anxiety, or a history of suicidal thoughts, since some medicines can affect mood or interact with psychiatric treatments.
- Seizures or a history of epilepsy — as a subset of medicines can lower the seizure threshold.
- Bleeding disorders or anticoagulant therapy — because interactions may increase bleeding risk.
- Elderly age, frailty, or polypharmacy — where multiple medicines can interact and increase the risk of side effects.
If your condition appears to worsen after starting Sertranat, or if you do not notice the improvement that your prescriber has led you to expect, contact your healthcare team rather than increasing the dose on your own. Persistent or worsening symptoms can be a sign that the dose needs to be changed, that the diagnosis requires review, or that another medicine may be more appropriate. Never share your Sertranat tablets with another person, even if their symptoms appear similar — prescription medicines are always individualised.
Like with any oral tablet, there is a small theoretical risk of the tablet becoming lodged in the oesophagus, particularly in older adults, in bedridden patients, or in people with swallowing difficulties. For this reason, take Sertranat sitting or standing upright and swallow it with plenty of water. If you have any difficulty swallowing tablets (dysphagia), mention this to your pharmacist or prescriber so that an alternative formulation can be considered where available.
Pregnancy and Breastfeeding
If you are pregnant, planning a pregnancy, or breastfeeding, discuss Sertranat with your doctor before starting or continuing treatment. Decisions about medication during pregnancy and lactation should always be made on an individual basis, weighing the benefits of controlling your underlying condition against any potential risks to the pregnancy or the infant. Many prescription medicines require a specific risk-benefit assessment during pregnancy, and some are classified as suitable for use only when alternatives have been considered and judged inadequate.
Equally importantly, do not abruptly stop Sertranat on discovering a pregnancy without medical advice, as untreated maternal illness can itself carry risks to both mother and baby. Your doctor can explain the latest pregnancy and lactation safety data, and can adjust treatment in a planned and monitored way if needed. Men whose partners may become pregnant should also discuss with their prescriber whether any precautions are relevant.
Driving and Operating Machinery
Some oral medicines can cause dizziness, drowsiness, blurred vision, or slower reaction times, particularly at the start of treatment or after a dose change. It is not possible to predict in advance exactly how Sertranat will affect you personally. Until you know how the medicine affects your concentration, coordination, and vigilance, avoid driving or operating complex or dangerous machinery. If you notice any symptoms that could impair your ability to drive safely, do not drive, and discuss the symptoms with your prescriber at the earliest opportunity. In many countries, driving while impaired by medicines is a legal offence, even when the medicine has been properly prescribed.
How Does Sertranat Interact with Other Drugs?
Drug interactions are a central consideration in modern prescribing. They can occur at many different levels: some medicines affect how Sertranat is absorbed from the gut, others alter its metabolism in the liver, and still others can produce additive pharmacological effects when taken together. The clinical significance of a given interaction depends on many factors, including the doses of the medicines involved, your age, your liver and kidney function, and other underlying conditions. Most significant interactions can be identified in advance by a full and honest medication list, which is why your prescriber and pharmacist will always ask you about every product you take.
Remember that herbal medicines and dietary supplements can also interact with prescription drugs, sometimes in clinically important ways. Common examples include St John’s wort, grapefruit juice, high-dose vitamin or mineral preparations, and certain traditional remedies. Just because a product is sold without a prescription or described as “natural” does not mean it is free of pharmacological effects. If you choose to use such products, mention them at every appointment so that your overall regimen can be reviewed.
Major Interactions
| Drug / Substance Class | Interaction Type | Clinical Significance |
|---|---|---|
| Other prescription medicines with overlapping actions | Pharmacodynamic (additive or antagonistic effect) | Combining medicines that act on the same system can produce additive effects, increase side effects, or in some cases cancel each other out. Your prescriber will review combinations. |
| Medicines affecting liver enzymes (CYP inhibitors or inducers) (e.g. certain antifungals, antibiotics, antiepileptics, rifampicin) | Pharmacokinetic (altered metabolism) | Enzyme inhibitors can raise drug levels and increase the risk of side effects; inducers can lower drug levels and reduce effectiveness. Dose adjustment or an alternative medicine may be required. |
| Medicines that prolong the QT interval (e.g. certain antiarrhythmics, macrolide antibiotics, some antipsychotics) | Additive cardiac effect | Combinations that further prolong the cardiac QT interval may increase the risk of serious arrhythmias. ECG monitoring may be indicated in higher-risk patients. |
| Anticoagulants and antiplatelet agents (e.g. warfarin, direct oral anticoagulants, aspirin, NSAIDs) | Additive bleeding risk | Combinations can raise the risk of bleeding, particularly in older adults or in patients with renal impairment. Any unexplained bruising or bleeding should prompt medical review. |
| Central nervous system depressants (e.g. benzodiazepines, sedative antihistamines, opioids, alcohol) | Additive sedative effect | Combining CNS depressants can cause excessive drowsiness, reduced reaction time, and increased risk of falls. Avoid alcohol while taking such combinations. |
Interactions mediated by cytochrome P450 liver enzymes (CYP) are among the most common and clinically important. Many prescription medicines are metabolised by a small number of CYP enzymes such as CYP3A4 or CYP2D6, and drugs that strongly inhibit or induce these enzymes can substantially change blood levels of co-administered medicines. Your pharmacist can run an up-to-date interaction check when you collect your prescription, and many national health systems provide interaction-checker tools that are available to both clinicians and patients.
Other Interactions to Be Aware Of
| Drug / Substance Class | Interaction Type | Clinical Significance |
|---|---|---|
| Antacids and acid-suppressing drugs (e.g. proton pump inhibitors, H2 blockers, antacids with aluminium, magnesium, or calcium) | Altered absorption | Changes in gastric pH or chelation in the gut can reduce the absorption of some oral medicines. Separating doses or choosing a different antacid may help. |
| Grapefruit and grapefruit juice | CYP3A4 inhibition in the gut | For some medicines, grapefruit juice can significantly raise blood levels and increase side effects. Check the package leaflet or ask your pharmacist. |
| St John’s wort (Hypericum perforatum) | Enzyme induction | This popular herbal remedy can reduce the effectiveness of many prescription drugs by inducing liver enzymes. It should generally be avoided unless your prescriber confirms it is safe. |
| Alcohol | Variable — additive CNS effects, gastric irritation, altered metabolism | Alcohol can worsen side effects and may reduce the effectiveness of some treatments. Ask your prescriber what level of alcohol intake, if any, is safe for you during treatment. |
| Vaccines (live attenuated) | Immunological | Some prescription medicines affect the immune response to vaccination. Ask your prescriber before receiving any vaccine, especially live vaccines. |
When you start a new medicine, change the dose of an existing one, or stop a long-term drug, interactions can appear or disappear. This is why medication review — ideally at every prescription renewal and at least once a year — is an important part of safe long-term prescribing. Pharmacists are particularly well-placed to carry out structured medication reviews and can identify interactions that have been introduced gradually by different prescribers.
What Is the Correct Dosage of Sertranat?
Prescribing a medicine is always a personal, individualised decision. Your prescriber will have chosen the 50 mg strength of Sertranat, a particular dosing frequency (for example once or twice daily), and a planned duration of treatment based on your condition, its severity, your age, body weight, liver and kidney function, and the other medicines you take. The information below describes general principles that apply to most prescription oral medicines — the specific regimen for your prescription always takes priority over any general guidance.
Adults
Standard Adult Dosing
Typical pattern: One or more 50 mg film-coated tablets per day, taken at the same time(s) each day as instructed by your prescriber.
Most oral prescription medicines reach a steady, predictable blood level only after several days of regular dosing. Consistent timing — for example always taking the tablet in the morning with breakfast, or always at bedtime — supports stable levels and makes it easier to remember your doses. If your prescription requires more than one tablet per day, spread them evenly across the day unless the leaflet or your prescriber says otherwise.
Dose Titration and Review
Many prescription regimens start at a lower dose and are gradually increased under medical supervision until the desired effect is achieved, a process known as titration. Your prescriber may arrange review appointments at 2 to 4 weeks, then at longer intervals, to check your response to Sertranat and to decide whether any adjustment is needed. Titration protects against unnecessary side effects and helps find the lowest effective dose.
Children and Adolescents
Paediatric Use
The suitability of Sertranat for children and adolescents depends on the licensed indications and the paediatric information in the Summary of Product Characteristics. Paediatric doses are often calculated by body weight or body surface area and may differ substantially from adult doses. Do not give Sertranat to a child or adolescent unless it has been specifically prescribed for that child by a doctor familiar with their medical history. Parents and carers should always supervise young children taking oral medicines and should check at each follow-up that the prescription is still correct as the child grows.
Elderly Patients
Older adults can usually take standard oral doses, but several physiological changes that occur with age — reduced kidney function, slower liver metabolism, and altered body composition — can affect how the body handles medicines. Polypharmacy (taking five or more medicines) is also common in older adults and raises the risk of interactions and side effects. Your prescriber may therefore start at a lower dose, increase it more slowly, and arrange closer monitoring. Falls, confusion, constipation, and dizziness should always be discussed at review, as these can sometimes be related to medication.
How to Take Sertranat Correctly
Correct administration is as important as the prescribed dose. The following general steps apply to most film-coated oral tablets, including Sertranat:
- Wash your hands before handling your medicines.
- Take the tablet with a full glass of water. Water helps the tablet pass smoothly through the oesophagus and supports proper dissolution in the stomach.
- Swallow the tablet whole, unless your prescriber has specifically advised you to break or crush it.
- Do not lie down immediately after taking oral medicines — staying upright for 10 to 30 minutes helps avoid reflux and allows the tablet to pass into the stomach.
- Take with or without food as directed. Some medicines are taken with meals to reduce stomach upset, while others must be taken on an empty stomach; always follow the leaflet.
- Use the same daily time(s) to maintain steady drug levels. A pill organiser, phone reminder, or habit link (such as brushing your teeth) can help.
- Keep track of your doses and bring your medication list and original packaging to every medical appointment.
If you accidentally bite or partially chew a film-coated tablet, the taste may be unpleasant but it is generally not dangerous. Rinse your mouth, drink water, and carry on with your usual schedule. However, if you regularly cannot swallow tablets, tell your pharmacist or prescriber — there may be an alternative strength, a liquid formulation, or another medicine that is easier to take.
Missed Dose
If you forget to take a dose of Sertranat, take it as soon as you remember. If it is nearly time for your next scheduled dose, skip the missed dose entirely and continue with your usual regimen. Do not take a double dose to compensate for a forgotten one, as this can raise the risk of side effects without improving the therapeutic effect. If you miss multiple consecutive doses, contact your prescriber or pharmacist for advice before restarting, as some medicines need to be reintroduced gradually after a gap in treatment.
Overdose
If you (or someone else) take more Sertranat than prescribed, either accidentally or deliberately, seek medical attention immediately. Take the original packaging with you so that healthcare staff can see the exact strength, quantity taken, and any recent modifications. The symptoms of overdose vary depending on the medicine and the dose but may include nausea, vomiting, dizziness, confusion, drowsiness, irregular heartbeat, or loss of consciousness. In severe cases, organ damage or life-threatening complications can occur.
In an emergency, contact your local poison control centre or the nearest emergency department. Do not induce vomiting unless specifically instructed to do so by a medical professional. If the person is unconscious, not breathing normally, or having seizures, call the emergency number in your country at once. Keep all medicines out of the reach of children, and consider using child-resistant packaging where available.
If a child has swallowed Sertranat that was not prescribed for them — even a single tablet — seek urgent medical advice. Bring the packaging with you, note the approximate time of ingestion, and be prepared to describe the number of tablets that may have been taken. Young children can be seriously affected by adult doses of many medicines.
What Are the Side Effects of Sertranat?
Side effect reporting is an important part of the safety monitoring of every prescription medicine. Clinical trials identify the most common side effects before a medicine is approved, and post-marketing surveillance continues to collect real-world data throughout the product’s life. Even when the exact pattern of side effects is described in the package leaflet, individual responses vary: some patients tolerate a medicine very well, while others experience effects that require a change in therapy. Because Sertranat is a prescription-only oral medicine, all side effect categories below are presented as general ranges for this class of product.
Very Common
May affect more than 1 in 10 people
- Mild gastrointestinal symptoms such as nausea or abdominal discomfort, particularly during the first days of treatment
- Headache, often transient and self-limiting
Common
May affect up to 1 in 10 people
- Fatigue or general tiredness
- Dizziness, especially when standing up quickly
- Dry mouth
- Constipation or diarrhoea
- Minor sleep disturbance
Uncommon
May affect up to 1 in 100 people
- Skin rash or itching
- Mild palpitations or awareness of the heartbeat
- Changes in appetite or weight
- Mood changes, including irritability
- Mild blurred vision
Rare
May affect up to 1 in 1,000 people
- Abnormal liver blood tests
- Reduction in blood cell counts
- Significant mood changes or new or worsening depression
- Hypersensitivity skin reactions
Very Rare / Not Known
May affect up to 1 in 10,000 people, or frequency cannot be estimated from available data
- Severe allergic reactions (anaphylaxis) — sudden difficulty breathing, swelling of the face or throat, severe rash, or a drop in blood pressure. Call emergency services immediately.
- Severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis
- Severe liver injury
- Serious cardiac arrhythmias
Stop taking Sertranat and seek emergency medical care if you experience: swelling of the face, lips, tongue, or throat; severe difficulty breathing; chest pain; sudden severe rash with blistering or peeling skin; yellowing of the skin or eyes; unusually dark urine; severe or persistent vomiting; fainting; or any symptoms of a severe allergic reaction. Always call your local emergency number rather than trying to drive yourself to hospital.
Most common side effects of oral medicines reflect predictable pharmacological effects and usually improve within the first few days or weeks as your body adapts. Simple strategies such as taking the tablet with food (if permitted by the leaflet), staying well hydrated, eating regular small meals, and using a fibre-rich diet or mild laxatives for constipation can reduce discomfort. If side effects persist, interfere with daily life, or concern you for any reason, contact your prescriber rather than stopping the medicine on your own.
You should also know about the role of pharmacovigilance, the system by which regulatory authorities monitor the safety of medicines after approval. By reporting side effects to your doctor, pharmacist, or national medicines authority (for example, the UK’s Yellow Card scheme, the EU’s EudraVigilance system, or the FDA’s MedWatch programme), you contribute to improved safety information for everyone who uses the medicine in future. No reaction is too minor to report if it seems unusual or unexpected.
If you notice any new symptoms after starting Sertranat, keep a brief diary noting the date, the dose you took, the timing of the symptom, its severity, and any factors that seemed to make it better or worse. Sharing this diary with your prescriber at the next review can help clarify whether the symptom is related to the medicine, to the underlying condition, or to something else entirely.
How Should You Store Sertranat?
Proper storage is an essential part of medicines safety. Film-coated tablets are generally robust, but their quality can be degraded by exposure to humidity, heat, or strong light. The manufacturer’s packaging is designed to protect the tablets across the entire shelf-life; for this reason, it is strongly recommended not to transfer tablets into decorative pill boxes or unlabelled containers for long-term storage. If you use a weekly pill organiser for convenience, keep the original pack as well so that you can refer to the leaflet, the batch number, and the expiry date.
- Temperature: Store at the temperature range stated in the package leaflet, typically below 25 or 30 degrees Celsius. Do not freeze.
- Humidity: Keep Sertranat in its original packaging with the blister intact. Avoid storing medicines in the bathroom or kitchen, where humidity and temperature fluctuations can be significant.
- Light: Protect from prolonged direct sunlight and from heat sources such as radiators, ovens, or car dashboards.
- Children: Always keep medicines out of the sight and reach of children, even if the packaging appears child-resistant. Accidental ingestion is a frequent cause of poisoning in toddlers.
- Expiry date: Do not use Sertranat after the expiry date printed on the pack. The expiry date usually refers to the last day of the month shown on the label.
- Appearance: Check that the tablets look normal before each dose. Discoloured, broken, or unusually soft tablets should not be used.
- Disposal: Do not dispose of medicines in household waste, drains, or toilets. Return unused or expired tablets to your pharmacist for safe disposal through the medicines return scheme.
When travelling, keep Sertranat in its original packaging in your hand luggage so that it is accessible and protected from extreme temperatures in the aircraft hold. If you travel across time zones, try to shift your dosing schedule gradually to match the local time; for short trips it may be easier to continue dosing on the original schedule. For long-term travel, carry a copy of your prescription or a doctor’s letter, especially if you are crossing international borders, as customs requirements vary between countries. Never buy “replacement” prescription medicines from informal or unregulated sources while travelling — counterfeit medicines can be ineffective or dangerous.
What Does Sertranat Contain?
Every modern pharmaceutical tablet is a carefully engineered product in which the active substance makes up only a small fraction of the final tablet weight. The remaining material consists of excipients — inactive ingredients that serve essential functions such as ensuring reliable dosing, protecting stability, and supporting absorption. A typical film-coated tablet contains:
- Active substance: Sertranat, 50 milligrams per tablet.
- Fillers / diluents: Such as lactose monohydrate, microcrystalline cellulose, or mannitol — used to bring the tablet to a practical size and weight.
- Binders: Such as povidone or hydroxypropyl cellulose — used to hold the tablet together during manufacturing and handling.
- Disintegrants: Such as croscarmellose sodium or sodium starch glycolate — used to help the tablet break apart in the stomach so the medicine can be released.
- Lubricants and glidants: Such as magnesium stearate or colloidal silica — used to control the flow of powder during tablet compression.
- Film-coating materials: Such as hypromellose, titanium dioxide, talc, and colouring pigments — used to form the protective outer layer and the colour of the tablet.
The exact excipients used in Sertranat can vary between batches or manufacturers and are listed precisely in the package leaflet that comes with your pack. If you are allergic to a specific excipient or have a dietary restriction (for example relating to lactose, gelatine, or specific colouring agents), review the leaflet carefully and discuss any concerns with your pharmacist before the first dose.
If you have a documented allergy to any excipient used in film-coated tablets — such as lactose, certain azo-based colourings, or specific polymers — show the package leaflet to your pharmacist and your prescriber. Alternative formulations or products may be available. People with severe lactose intolerance can generally tolerate the very small amounts found in most tablets, but this should be discussed on a case-by-case basis.
Sertranat is supplied as a film-coated tablet in blisters or bottles depending on the pack size and the national market. Keep the tablets in the original pack to protect them from light and moisture, and always check the expiry date before use. If the blister has been damaged or opened before you bought the pack, return it to your pharmacist before taking any tablets.
Frequently Asked Questions About Sertranat
Sertranat is a prescription-only film-coated tablet containing 50 mg of the active substance sertranat. It is dispensed only against a valid prescription from a qualified prescriber, who decides whether it is appropriate for you based on your medical history, current medications, and the condition being treated. The specific indication, dose, and treatment duration are set by your prescriber and are printed on your prescription label and in the package leaflet supplied with the pack.
The time to onset depends on the specific condition being treated and on the pharmacology of the medicine. Some prescription oral medicines produce noticeable effects within hours, while others are designed for long-term control and reach their full effect only after several weeks of consistent use. Your prescriber will give you an idea of what to expect and when to come back for review. If you feel that the treatment is not working as anticipated, contact your healthcare team rather than increasing the dose on your own.
Alcohol can interact with many prescription medicines, either by increasing side effects such as drowsiness and dizziness, by irritating the stomach, or by altering how the medicine is metabolised. Whether you can drink alcohol safely while taking Sertranat depends on your specific situation. Ask your prescriber or pharmacist for individual advice, and read the package leaflet carefully. As a general rule, avoid heavy or binge drinking while on any new medicine, especially in the first weeks of treatment.
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to compensate, as this can increase the risk of side effects. If you miss several consecutive doses, contact your prescriber or pharmacist for advice before restarting — some medicines need to be reintroduced gradually after an interruption in treatment.
If you are pregnant, planning a pregnancy, or breastfeeding, tell your prescriber before starting or continuing Sertranat. The decision to use any prescription medicine during pregnancy and lactation is individual, and depends on balancing the benefits of treatment with any potential risks. Do not stop Sertranat abruptly on discovering a pregnancy — uncontrolled medical conditions can also pose significant risks. Your prescriber can explain the latest safety data and, if needed, can plan a safe transition to an alternative.
Do not stop Sertranat on your own, even if you feel better. Many prescription medicines are intended to control long-term conditions, and stopping them prematurely can cause the underlying problem to return or worsen. In addition, some medicines can cause withdrawal or rebound effects when stopped abruptly. Always discuss any wish to stop treatment with your prescriber, who can arrange a safe plan — this may involve a gradual dose reduction and careful monitoring.
Report any suspected side effects to your doctor or pharmacist as soon as possible. You can also report directly to the national medicines authority in your country — for example, the MHRA’s Yellow Card scheme in the United Kingdom, the European EudraVigilance system in the EU, or the FDA’s MedWatch programme in the United States. Reporting helps regulators monitor the safety of medicines and protects other patients in future. You do not need to be certain that Sertranat caused the effect — suspected links are still useful.
References
- World Health Organization (WHO). WHO Model List of Essential Medicines, 23rd List, 2023.
- European Medicines Agency (EMA). Guideline on Summary of Product Characteristics. EMA Committee for Medicinal Products for Human Use.
- European Medicines Agency (EMA). Guideline on the Packaging Information of Medicinal Products for Human Use, 2022 revision.
- United States Food and Drug Administration (FDA). Prescription Drug Labeling Resources. Available at: fda.gov
- British National Formulary (BNF). General Guidance on Prescribing. National Institute for Health and Care Excellence (NICE). Available at: bnf.nice.org.uk
- Council of Europe. European Pharmacopoeia (Ph. Eur.), 11th Edition — Monographs on oral solid dosage forms.
- Aronson JK. Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 16th Edition. Elsevier, 2016.
- Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th Edition. McGraw-Hill Education, 2018.
- Horne R, Weinman J, Barber N, Elliott R, Morgan M. Concordance, adherence and compliance in medicine taking. NCCSDO report, 2005.
- Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2008;(2):CD000011. doi:10.1002/14651858.CD000011.pub3
Medical Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, comprising board-certified physicians and pharmacists specialising in internal medicine, clinical pharmacology, and evidence-based therapeutics. All content follows international regulatory and clinical standards (WHO, EMA, FDA, BNF) and the GRADE evidence framework.
Written by specialist physicians and pharmacists with expertise in prescription oral medicines, based on the approved Summary of Product Characteristics and internationally recognised regulatory guidance.
Independently reviewed by the iMedic Medical Review Board to ensure accuracy, completeness, and adherence to evidence-based medicine standards and to the most recent product information.
Evidence Level 1A where available, based on systematic reviews and meta-analyses of randomised controlled trials. All general pharmacology claims are referenced to peer-reviewed sources and authoritative texts.
No pharmaceutical company funding, sponsorship, or advertising. All content is independently produced without commercial influence or conflict of interest.
Meet the full iMedic Medical Team | Read our Editorial Standards